{"id":"https://openalex.org/W2314965359","doi":"https://doi.org/10.1158/1538-7445.am2012-4077","title":"Abstract 4077: Chemosensitizing effects of the novel, small molecule DNA methylation inhibitor SGI-110 in ovarian cancer","display_name":"Abstract 4077: Chemosensitizing effects of the novel, small molecule DNA methylation inhibitor SGI-110 in ovarian cancer","publication_year":2012,"publication_date":"2012-04-01","ids":{"openalex":"https://openalex.org/W2314965359","doi":"https://doi.org/10.1158/1538-7445.am2012-4077","mag":"2314965359"},"language":"en","primary_location":{"id":"doi:10.1158/1538-7445.am2012-4077","doi":"https://doi.org/10.1158/1538-7445.am2012-4077","is_oa":false,"landing_page_url":"https://doi.org/10.1158/1538-7445.am2012-4077","pdf_url":null,"source":{"id":"https://openalex.org/S168522863","display_name":"Cancer Research","issn_l":"0008-5472","issn":["0008-5472","1538-7445"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Research","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5067743297","display_name":"Daniela Elena Matei","orcid":"https://orcid.org/0000-0003-2169-5035","observed_orcids":["https://orcid.org/0000-0003-2169-5035"]},"institutions":[{"id":"https://openalex.org/I4388446366","display_name":"Indiana University Indianapolis","ror":"https://ror.org/03eftgw80","country_code":"US","type":"education","lineage":["https://openalex.org/I4388446366","https://openalex.org/I592451"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Daniela Matei","raw_affiliation_strings":["1Indiana University, Indianapolis, IN"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Indiana University, Indianapolis, IN","institution_ids":["https://openalex.org/I4388446366"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5018689852","display_name":"Pietro Taverna","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Pietro Taverna","raw_affiliation_strings":["2Astex Pharmaceuticals, Dublin, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2Astex Pharmaceuticals, Dublin, CA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5108561206","display_name":"Davied Miller","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210119109","display_name":"Indiana University Bloomington","ror":"https://ror.org/02k40bc56","country_code":"US","type":"education","lineage":["https://openalex.org/I4210119109","https://openalex.org/I592451"]},{"id":"https://openalex.org/I592451","display_name":"Indiana University","ror":"https://ror.org/01kg8sb98","country_code":"US","type":"education","lineage":["https://openalex.org/I592451"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Davied Miller","raw_affiliation_strings":["3Indiana University, Bloomington, IN"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"3Indiana University, Bloomington, IN","institution_ids":["https://openalex.org/I4210119109","https://openalex.org/I592451"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5059806286","display_name":"Fang Fang","orcid":"https://orcid.org/0000-0001-9829-2934","observed_orcids":["https://orcid.org/0000-0001-9829-2934"]},"institutions":[{"id":"https://openalex.org/I4210119109","display_name":"Indiana University Bloomington","ror":"https://ror.org/02k40bc56","country_code":"US","type":"education","lineage":["https://openalex.org/I4210119109","https://openalex.org/I592451"]},{"id":"https://openalex.org/I592451","display_name":"Indiana University","ror":"https://ror.org/01kg8sb98","country_code":"US","type":"education","lineage":["https://openalex.org/I592451"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Fang Fang","raw_affiliation_strings":["3Indiana University, Bloomington, IN"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"3Indiana University, Bloomington, IN","institution_ids":["https://openalex.org/I4210119109","https://openalex.org/I592451"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5040528044","display_name":"Jiyoon Lee","orcid":"https://orcid.org/0000-0002-5561-5331","observed_orcids":["https://orcid.org/0000-0002-5561-5331"]},"institutions":[{"id":"https://openalex.org/I4388446366","display_name":"Indiana University Indianapolis","ror":"https://ror.org/03eftgw80","country_code":"US","type":"education","lineage":["https://openalex.org/I4388446366","https://openalex.org/I592451"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Jiyoon Lee","raw_affiliation_strings":["1Indiana University, Indianapolis, IN"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Indiana University, Indianapolis, IN","institution_ids":["https://openalex.org/I4388446366"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5112478938","display_name":"Minghai Shao","orcid":"https://orcid.org/0009-0002-6571-4082","observed_orcids":["https://orcid.org/0009-0002-6571-4082"]},"institutions":[{"id":"https://openalex.org/I4388446366","display_name":"Indiana University Indianapolis","ror":"https://ror.org/03eftgw80","country_code":"US","type":"education","lineage":["https://openalex.org/I4388446366","https://openalex.org/I592451"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Minghai Shao","raw_affiliation_strings":["1Indiana University, Indianapolis, IN"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Indiana University, Indianapolis, IN","institution_ids":["https://openalex.org/I4388446366"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5045501967","display_name":"Jay M. Pilrose","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210119109","display_name":"Indiana University Bloomington","ror":"https://ror.org/02k40bc56","country_code":"US","type":"education","lineage":["https://openalex.org/I4210119109","https://openalex.org/I592451"]},{"id":"https://openalex.org/I592451","display_name":"Indiana University","ror":"https://ror.org/01kg8sb98","country_code":"US","type":"education","lineage":["https://openalex.org/I592451"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Jay Pilrose","raw_affiliation_strings":["3Indiana University, Bloomington, IN"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"3Indiana University, Bloomington, IN","institution_ids":["https://openalex.org/I4210119109","https://openalex.org/I592451"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5039840799","display_name":"Gavin S. Choy","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Gavin Choy","raw_affiliation_strings":["2Astex Pharmaceuticals, Dublin, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2Astex Pharmaceuticals, Dublin, CA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5019816977","display_name":"Mohammad Azab","orcid":"https://orcid.org/0009-0001-8837-6613","observed_orcids":["https://orcid.org/0009-0001-8837-6613"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Mohammad Azab","raw_affiliation_strings":["2Astex Pharmaceuticals, Dublin, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2Astex Pharmaceuticals, Dublin, CA","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5031899354","display_name":"Kennethe Nephew","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210119109","display_name":"Indiana University Bloomington","ror":"https://ror.org/02k40bc56","country_code":"US","type":"education","lineage":["https://openalex.org/I4210119109","https://openalex.org/I592451"]},{"id":"https://openalex.org/I592451","display_name":"Indiana University","ror":"https://ror.org/01kg8sb98","country_code":"US","type":"education","lineage":["https://openalex.org/I592451"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Kennethe Nephew","raw_affiliation_strings":["3Indiana University, Bloomington, IN"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"3Indiana University, Bloomington, IN","institution_ids":["https://openalex.org/I4210119109","https://openalex.org/I592451"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":3,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"72","issue":"8_Supplement","first_page":"4077","last_page":"4077"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10269","display_name":"Epigenetics and DNA Methylation","score":0.9199000000953674,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10269","display_name":"Epigenetics and DNA Methylation","score":0.9199000000953674,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10550","display_name":"Ovarian cancer diagnosis and treatment","score":0.06790000200271606,"subfield":{"id":"https://openalex.org/subfields/2743","display_name":"Reproductive Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10129","display_name":"Glioma Diagnosis and Treatment","score":0.0017000000225380063,"subfield":{"id":"https://openalex.org/subfields/2716","display_name":"Genetics (clinical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/sgi-110","display_name":"SGI-110","score":0.9800000190734863},{"id":"https://openalex.org/keywords/dna-methylation-inhibitors","display_name":"DNA methylation inhibitors","score":0.6710000038146973},{"id":"https://openalex.org/keywords/ovarian-cancer","display_name":"ovarian cancer","score":0.7900000214576721},{"id":"https://openalex.org/keywords/chemosensitization","display_name":"chemosensitization","score":0.875},{"id":"https://openalex.org/keywords/cisplatin-resistance","display_name":"cisplatin resistance","score":0.9399999976158142},{"id":"https://openalex.org/keywords/hypomethylating-agents","display_name":"hypomethylating agents","score":0.6959999799728394},{"id":"https://openalex.org/keywords/tumor-suppressor-genes","display_name":"tumor suppressor","score":0.828000009059906},{"id":"https://openalex.org/keywords/rassf1a","display_name":"RASSF1A","score":0.9110000133514404},{"id":"https://openalex.org/keywords/mlh1","display_name":"MLH1","score":0.9980000257492065},{"id":"https://openalex.org/keywords/hoxa10","display_name":"HOXA10","score":0.9879999756813049},{"id":"https://openalex.org/keywords/epithelial-mesenchymal-transition","display_name":"epithelial-mesenchymal transition","score":0.8640000224113464},{"id":"https://openalex.org/keywords/transforming-growth-factor-beta","display_name":"TGF-beta","score":0.703000009059906},{"id":"https://openalex.org/keywords/decitabine","display_name":"decitabine","score":0.906000018119812}],"concepts":[{"id":"https://openalex.org/C2780235182","wikidata":"https://www.wikidata.org/wiki/Q1181878","display_name":"Decitabine","level":5,"score":0.8289065361022949},{"id":"https://openalex.org/C2778239845","wikidata":"https://www.wikidata.org/wiki/Q412415","display_name":"Cisplatin","level":3,"score":0.7190419435501099},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.6387938857078552},{"id":"https://openalex.org/C190727270","wikidata":"https://www.wikidata.org/wiki/Q874745","display_name":"DNA methylation","level":4,"score":0.5658053159713745},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.5141203999519348},{"id":"https://openalex.org/C2780427987","wikidata":"https://www.wikidata.org/wiki/Q172341","display_name":"Ovarian cancer","level":3,"score":0.444879412651062},{"id":"https://openalex.org/C2776012956","wikidata":"https://www.wikidata.org/wiki/Q17125294","display_name":"Hypomethylating agent","level":5,"score":0.4386414885520935},{"id":"https://openalex.org/C41091548","wikidata":"https://www.wikidata.org/wiki/Q26939","display_name":"Epigenetics","level":3,"score":0.4299495816230774},{"id":"https://openalex.org/C16824249","wikidata":"https://www.wikidata.org/wiki/Q5205753","display_name":"DNA demethylation","level":5,"score":0.41656947135925293},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.40655314922332764},{"id":"https://openalex.org/C153911025","wikidata":"https://www.wikidata.org/wiki/Q7202","display_name":"Molecular biology","level":1,"score":0.3886132836341858},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.34761345386505127},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.327080100774765},{"id":"https://openalex.org/C54355233","wikidata":"https://www.wikidata.org/wiki/Q7162","display_name":"Genetics","level":1,"score":0.15925979614257812},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.14655348658561707},{"id":"https://openalex.org/C150194340","wikidata":"https://www.wikidata.org/wiki/Q26972","display_name":"Gene expression","level":3,"score":0.13256296515464783},{"id":"https://openalex.org/C104317684","wikidata":"https://www.wikidata.org/wiki/Q7187","display_name":"Gene","level":2,"score":0.12412256002426147}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1158/1538-7445.am2012-4077","doi":"https://doi.org/10.1158/1538-7445.am2012-4077","is_oa":false,"landing_page_url":"https://doi.org/10.1158/1538-7445.am2012-4077","pdf_url":null,"source":{"id":"https://openalex.org/S168522863","display_name":"Cancer Research","issn_l":"0008-5472","issn":["0008-5472","1538-7445"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Research","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.9476000070571899,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2327247651","https://openalex.org/W2111836054","https://openalex.org/W1998926004","https://openalex.org/W1585915268","https://openalex.org/W1993170446","https://openalex.org/W2604675241","https://openalex.org/W2564807661","https://openalex.org/W1917543987","https://openalex.org/W1992438096","https://openalex.org/W2400896868"],"abstract_inverted_index":{"Abstract":[0],"Deoxycytosine":[1],"methylation":[2,40,45,275],"of":[3,9,23,80,161,189,214,254,263,288,337,369,383,393,414,425,430],"CpG":[4],"islands":[5],"in":[6,18,32,50,55,70,75,138,141,159,192,207,283,292,296,344,372,385],"promoter":[7,274],"regions":[8],"tumor":[10],"suppressor":[11],"genes":[12],"(TSGs)":[13],"plays":[14],"a":[15,33,63,84,113,407],"prominent":[16],"role":[17],"the":[19,38,187,201,227,282,320,381,391,412,426,431],"development":[20],"and":[21,46,100,112,116,132,135,140,194,221,226,234,260,267,286,291,312],"progression":[22],"drug-resistant":[24,150],"epithelial":[25,250],"ovarian":[26,151,397,415],"cancer":[27,76,152,398],"(OC).":[28],"We":[29,121,279,377],"previously":[30],"demonstrated":[31,68],"phase":[34],"I/II":[35],"trial":[36],"that":[37],"DNA":[39,44,64,81],"inhibitor":[41],"decitabine":[42],"alters":[43],"restores":[47],"platinum":[48,165,394,405],"sensitivity":[49],"platinum-resistant":[51],"OC":[52,129,167,255],"patients,":[53],"resulting":[54],"significant":[56,212,361],"clinical":[57,409],"activity.":[58],"SGI-110":[59,87,123,148,169,182,210,244,246,271,307,323,338,351,359,384,402],"(Astex":[60],"Pharmaceuticals)":[61],"is":[62,406],"hypomethylating":[65],"agent":[66],"with":[67,147,294,306,346,387,404],"activity":[69,382],"restoring":[71],"silenced":[72],"TSG":[73],"expression":[74,269],"cells":[77,191],"by":[78,97,177,185,261,277,366],"reversal":[79],"methylation.":[82],"As":[83],"decitabine-deoxyguanosine":[85],"dinucleotide,":[86],"has":[88],"been":[89],"shown":[90],"to":[91,95,127,133,155,251,389],"be":[92],"less":[93,110,117],"prone":[94],"deamination":[96],"cytidine":[98],"deaminase":[99],"could":[101],"have":[102],"advantages":[103],"over":[104],"decitabine,":[105],"such":[106],"as":[107,257,364],"better":[108],"stability,":[109],"toxicity":[111],"more":[114],"convenient":[115],"frequent":[118],"SQ":[119],"administration.":[120],"examined":[122,281],"for":[124,171,411,434],"its":[125],"ability":[126],"inhibit":[128],"cell":[130,153,203],"proliferation":[131],"demethylate":[134],"induce":[136],"TSGs":[137,215],"vitro":[139],"vivo.":[142],"A":[143],"48":[144,242],"hour":[145,243],"pretreatment":[146],"resensitized":[149],"lines":[154],"cisplatin":[156,175,310,329,349,355,388],"(3-fold":[157],"reduction":[158],"IC50":[160,176],"cisplatin).":[162],"In":[163,319,400],"A2780":[164,195],"sensitive":[166],"cells,":[168,196,256],"pre-treatment":[170],"5":[172],"days":[173],"reduced":[174,184],">2-fold.":[178],"Prolonged":[179],"(7":[180],"days)":[181],"treatment":[183],"2-fold":[186],"number":[188],"ALDH1+":[190],"SKOV3":[193],"suggesting":[197],"an":[198],"effect":[199],"on":[200],"stem":[202],"population,":[204],"potentially":[205],"involved":[206],"drug":[208],"resistance.":[209],"induced":[211,249,276,360],"demethylation":[213,371],"ras-associated":[216],"domain":[217],"family":[218],"1A":[219],"(RASSF1A)":[220],"human":[222,396],"MutL":[223],"homologue-1":[224],"(MLH1)":[225],"differentiation-associated":[228],"gene":[229,236],"HOXA10;":[230],"furthermore,":[231],"RASSF1A,":[232],"MLH1":[233],"HOXA10":[235],"reexpression":[237],"was":[238,330,339,356],"also":[239],"observed":[240],"after":[241],"treatment.":[245],"prevented":[247],"TGF-\u03b2":[248],"mesenchymal":[252],"transition":[253],"measured":[258,316],"morphologically":[259],"quantification":[262],"E-cadherin,":[264],"Zeb1,":[265],"Slug":[266],"miR200c":[268],"levels.":[270],"suppressed":[272],"E-cadherin":[273],"TGF-\u03b2.":[278],"then":[280],"vivo":[284],"tolerability":[285],"efficacy":[287],"SGI-110,":[289],"singly":[290],"combination":[293,345,386,410],"cisplatin,":[295],"nude":[297],"athymic":[298],"mice.":[299],"Mice":[300],"were":[301,315],"injected":[302],"qd":[303,321],"or":[304,343],"bi-weekly":[305,335],"(sc)":[308],"and/or":[309],"(ip)":[311],"body":[313],"weights":[314],"twice":[317],"weekly.":[318],"regimen,":[322],"2":[324,347],"mg/kg":[325,328,334,348,354],"plus":[326,352],"4":[327,353],"tolerated.":[331],"The":[332],"10":[333],"dose":[336],"tolerated,":[340],"either":[341],"alone":[342],"(5mg/kg":[350],"similarly":[357],"tolerated).":[358],"global":[362],"hypomethylation,":[363],"determined":[365],"pyrosequencing":[367],"analysis":[368],"LINE1":[370],"peripheral":[373],"blood":[374],"mononuclear":[375],"cells.":[376],"are":[378],"currently":[379],"assessing":[380],"retard":[390],"growth":[392],"resistant":[395],"xenografts.":[399],"summary,":[401],"combined":[403],"promising":[408],"therapy":[413],"cancer.":[416],"Citation":[417],"Format:":[418],"{Authors}.":[419],"{Abstract":[420],"title}":[421],"[abstract].":[422],"In:":[423],"Proceedings":[424],"103rd":[427],"Annual":[428],"Meeting":[429],"American":[432],"Association":[433],"Cancer":[435,446],"Research;":[436],"2012":[437],"Mar":[438],"31-Apr":[439],"4;":[440],"Chicago,":[441],"IL.":[442],"Philadelphia":[443],"(PA):":[444],"AACR;":[445],"Res":[447],"2012;72(8":[448],"Suppl):Abstract":[449],"nr":[450],"4077.":[451],"doi:1538-7445.AM2012-4077":[452]},"counts_by_year":[],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2016-06-24T00:00:00"}